Tafelmeier, M., Baessler, A., Wagner, S., Unsoeld, B., Preveden, A., Barlocco, F., . . . Maier, L. S. (2020). Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy. Clin Cardiol.
Styl cytowania ChicagoTafelmeier, Maria, et al. "Design of the SILICOFCM Study: Effect of Sacubitril/valsartan Vs Lifestyle Intervention On Functional Capacity in Patients With Hypertrophic Cardiomyopathy." Clin Cardiol 2020.
Styl cytowania MLATafelmeier, Maria, et al. "Design of the SILICOFCM Study: Effect of Sacubitril/valsartan Vs Lifestyle Intervention On Functional Capacity in Patients With Hypertrophic Cardiomyopathy." Clin Cardiol 2020.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..